• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脊髓灰质炎病毒Sabin疫苗不同再分离株VP1区域异常突变的检测

Detection of unusual mutation within the VP1 region of different re-isolates of poliovirus Sabin vaccine.

作者信息

Dedepsidis Evaggelos, Karakasiliotis Ioannis, Paximadi Eleni, Kyriakopoulou Zaharoula, Komiotis Dimitrios, Markoulatos Panayotis

机构信息

Department of Biochemistry & Biotechnology, School of Health Sciences, University of Thessaly, Ploutonos 26 & Aiolou, 41221 Larissa, Greece.

出版信息

Virus Genes. 2006 Oct;33(2):183-91. doi: 10.1007/s11262-005-0055-3.

DOI:10.1007/s11262-005-0055-3
PMID:16972033
Abstract

In the present study, a genomic analysis of full VP1 sequence region of 15 clinical re-isolates (14 healthy vaccinees and one bone marrow tumor patient) was conducted, aiming to the identification of mutations and to the assessment of their impact on virus fitness, providing also insights relevant with the natural evolution of Sabin strains. Clinical re-isolates were analyzed by RT-PCR, sequencing and computational analysis. Some re-isolates were characterized by an unusual mutational pattern in which non-synonymous mutations outnumbered the synonymous ones. Furthermore, the majority of amino-acid substitutions were located in the capsid exterior, specifically in N-Ags, near N-Ags and in the north rim of the canyon. Also mutations, which are well-known determinants of attenuation, were identified. The results of this study propose that some re-isolates are characterized by an evolutionary pattern in which non-synonymous mutations with a direct phenotypic impact on viral fitness are fixed in viral genomes, in spite of synonymous ones with no phenotypic impact on viral fitness. Results of the present retrospective characterization of Sabin clinical re-isolates, based on the full VP1 sequence, suggest that vaccine-derived viruses may make their way through narrow breaches and may evolve into transmissible pathogens even in adequately immunized populations. For this reason increased poliovirus laboratory surveillance should be permanent and full VP1 sequence analysis should be conducted even in isolates originating from healthy vaccinees.

摘要

在本研究中,对15株临床再分离株(14名健康疫苗接种者和1名骨髓肿瘤患者)的完整VP1序列区域进行了基因组分析,旨在识别突变并评估其对病毒适应性的影响,同时也为了解萨宾株的自然进化提供见解。通过逆转录聚合酶链反应(RT-PCR)、测序和计算分析对临床再分离株进行了分析。一些再分离株具有不寻常的突变模式,其中非同义突变的数量超过同义突变。此外,大多数氨基酸替换位于衣壳外部,特别是在N抗原、N抗原附近以及峡谷的北缘。还鉴定出了一些众所周知的减毒决定因素的突变。本研究结果表明,一些再分离株具有一种进化模式,即对病毒适应性有直接表型影响的非同义突变在病毒基因组中固定下来,尽管同义突变对病毒适应性没有表型影响。基于完整VP1序列对萨宾临床再分离株进行的本次回顾性特征分析结果表明,疫苗衍生病毒可能通过狭窄的缺口传播,甚至在免疫充分的人群中也可能进化为可传播的病原体。因此,应持续加强脊髓灰质炎病毒实验室监测,即使是来自健康疫苗接种者的分离株也应进行完整的VP1序列分析。

相似文献

1
Detection of unusual mutation within the VP1 region of different re-isolates of poliovirus Sabin vaccine.脊髓灰质炎病毒Sabin疫苗不同再分离株VP1区域异常突变的检测
Virus Genes. 2006 Oct;33(2):183-91. doi: 10.1007/s11262-005-0055-3.
2
Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1.从一名健康疫苗接种者体内分离出的、含有嵌合衣壳蛋白VP1的重组3型/2型脊髓灰质炎病毒的特性分析
J Gen Virol. 2003 Mar;84(Pt 3):573-580. doi: 10.1099/vir.0.18708-0.
3
Use of mutational pattern in 5'-NCR and VP1 regions of polioviruses for molecular diagnosis.利用脊髓灰质炎病毒5'-非编码区和VP1区的突变模式进行分子诊断。
Mol Cell Probes. 2007 Aug;21(4):267-75. doi: 10.1016/j.mcp.2007.01.004. Epub 2007 Jan 25.
4
Evolution of type 2 vaccine derived poliovirus lineages. Evidence for codon-specific positive selection at three distinct locations on capsid wall.2 型疫苗衍生脊髓灰质炎病毒谱系的演变。在衣壳壁上三个不同位置存在密码子特异性正选择的证据。
PLoS One. 2013 Jun 28;8(6):e66836. doi: 10.1371/journal.pone.0066836. Print 2013.
5
Identification of a consistent pattern of mutations in neurovirulent variants derived from the sabin vaccine strain of poliovirus type 2.2型脊髓灰质炎病毒萨宾疫苗株衍生的神经毒力变异株中一致突变模式的鉴定
J Virol. 1991 May;65(5):2707-10. doi: 10.1128/JVI.65.5.2707-2710.1991.
6
Complete genomic characterization of an intertypic Sabin 3/Sabin 2 capsid recombinant.一种Sabin 3/Sabin 2衣壳重组体的全基因组特征分析
FEMS Immunol Med Microbiol. 2008 Apr;52(3):343-51. doi: 10.1111/j.1574-695X.2008.00381.x. Epub 2008 Mar 6.
7
Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates.脊髓灰质炎病毒2型Sabin疫苗株在灵长类动物中减毒的遗传基础。
Virology. 1993 Jan;192(1):18-26. doi: 10.1006/viro.1993.1003.
8
Type 2 poliovirus recombinants isolated from vaccine-associated cases and from healthy contacts in Brazil.从巴西疫苗相关病例和健康接触者中分离出的2型脊髓灰质炎病毒重组体。
Acta Virol. 1996 Feb;40(1):27-33.
9
Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: a unifying model.免疫缺陷患者体内循环野生脊髓灰质炎病毒和疫苗衍生脊髓灰质炎病毒的演变:一个统一模型
J Virol. 2000 Aug;74(16):7381-90. doi: 10.1128/jvi.74.16.7381-7390.2000.
10
Long-term excretion of vaccine-derived poliovirus by a healthy child.一名健康儿童长期排泄疫苗衍生脊髓灰质炎病毒。
J Virol. 2004 Dec;78(24):13839-47. doi: 10.1128/JVI.78.24.13839-13847.2004.

引用本文的文献

1
The Early Evolution of Oral Poliovirus Vaccine Is Shaped by Strong Positive Selection and Tight Transmission Bottlenecks.口服脊髓灰质炎疫苗的早期进化受到强烈的正选择和严格的传播瓶颈的影响。
Cell Host Microbe. 2021 Jan 13;29(1):32-43.e4. doi: 10.1016/j.chom.2020.10.011. Epub 2020 Nov 18.
2
The Evolutionary Pathway to Virulence of an RNA Virus.一种RNA病毒毒力的进化途径
Cell. 2017 Mar 23;169(1):35-46.e19. doi: 10.1016/j.cell.2017.03.013.
3
Correlation of mutations and recombination with growth kinetics of poliovirus vaccine strains.

本文引用的文献

1
Evolution of a rare vaccine-derived multirecombinant poliovirus.一种罕见的疫苗衍生多重组脊髓灰质炎病毒的演变
J Gen Virol. 2005 Nov;86(Pt 11):3137-3142. doi: 10.1099/vir.0.80823-0.
2
Intratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient.在一名免疫缺陷患者慢性感染期间出现的1型疫苗衍生脊髓灰质炎病毒谱系间的型内重组。
J Virol. 2005 Oct;79(20):12623-34. doi: 10.1128/JVI.79.20.12623-12634.2005.
3
Isolation of vaccine-derived polioviruses in the Slovak Republic.
突变和重组与脊髓灰质炎疫苗株生长动力学的相关性。
Eur J Clin Microbiol Infect Dis. 2010 Dec;29(12):1513-23. doi: 10.1007/s10096-010-1033-9. Epub 2010 Sep 5.
4
Growth kinetic analysis of bi-recombinant poliovirus vaccine strains.双重组脊髓灰质炎病毒疫苗株的生长动力学分析
Virus Genes. 2010 Apr;40(2):200-11. doi: 10.1007/s11262-010-0448-9. Epub 2010 Jan 21.
5
Shedding of vaccine viruses with increased antigenic and genetic divergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine.新生儿接种单价1型口服脊髓灰质炎疫苗后,疫苗病毒的脱落以及抗原性和基因差异增加。
J Virol. 2009 Sep;83(17):8693-704. doi: 10.1128/JVI.02388-08. Epub 2009 Jun 10.
6
Environmental poliovirus surveillance during oral poliovirus vaccine and inactivated poliovirus vaccine use in Córdoba Province, Argentina.在阿根廷科尔多瓦省使用口服脊髓灰质炎疫苗和灭活脊髓灰质炎疫苗期间开展的环境脊髓灰质炎病毒监测
Appl Environ Microbiol. 2009 Mar;75(5):1395-401. doi: 10.1128/AEM.02201-08. Epub 2009 Jan 5.
7
Retrospective characterization of a vaccine-derived poliovirus type 1 isolate from sewage in Greece.希腊污水中一株1型疫苗衍生脊髓灰质炎病毒分离株的回顾性特征分析
Appl Environ Microbiol. 2007 Nov;73(21):6697-704. doi: 10.1128/AEM.00535-07. Epub 2007 Sep 7.
在斯洛伐克共和国分离出疫苗衍生脊髓灰质炎病毒。
Eur J Clin Microbiol Infect Dis. 2005 Jun;24(6):438-9. doi: 10.1007/s10096-005-1331-9.
4
Polio eradication: the OPV paradox.消灭脊髓灰质炎:口服脊髓灰质炎疫苗的悖论
Rev Med Virol. 2003 Sep-Oct;13(5):277-91. doi: 10.1002/rmv.401.
5
Progress towards global eradication of poliomyelitis, 2002.2002年全球根除脊髓灰质炎的进展
Wkly Epidemiol Rec. 2003 Apr 25;78(17):138-44.
6
Long-term circulation of vaccine-derived poliovirus that causes paralytic disease.导致麻痹性疾病的疫苗衍生脊髓灰质炎病毒的长期传播。
J Virol. 2002 Jul;76(13):6791-9. doi: 10.1128/jvi.76.13.6791-6799.2002.
7
Acute flaccid paralysis associated with circulating vaccine-derived poliovirus--Philippines, 2001.2001年菲律宾出现与循环疫苗衍生脊髓灰质炎病毒相关的急性弛缓性麻痹病例
MMWR Morb Mortal Wkly Rep. 2001 Oct 12;50(40):874-5.
8
Update: Outbreak of poliomyelitis--Dominican Republic and Haiti, 2000-2001.最新消息:2000 - 2001年多米尼加共和国和海地脊髓灰质炎疫情
MMWR Morb Mortal Wkly Rep. 2001 Oct 5;50(39):855-6.
9
Circulation of a type 2 vaccine-derived poliovirus--Egypt, 1982-1993.2型疫苗衍生脊髓灰质炎病毒的传播——埃及,1982 - 1993年
MMWR Morb Mortal Wkly Rep. 2001 Jan 26;50(3):41-2, 51.
10
Improved genotyping vaccine and wild-type poliovirus strains by restriction fragment length polymorphism analysis: clinical diagnostic implications.通过限制性片段长度多态性分析改进基因分型疫苗株和野生型脊髓灰质炎病毒株:临床诊断意义
J Clin Microbiol. 2000 Dec;38(12):4337-42. doi: 10.1128/JCM.38.12.4337-4342.2000.